ArticleCancer immunology, immunotherapy : CII2025

SUMO modified ETV1 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by facilitating CCL2 transcription in esophageal squamous cell carcinoma cells.

Tianci Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.